Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptorelin 6-month formulation in advanced prostate cancer
NCT00751790Phase 3Completed
- Sponsor
- Debiopharm
- Start
- Jul 2006
- Primary completion
- Aug 2007
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of triptorelin in prostate cancer (PCa), sponsored by Debiopharm. Primary endpoint: Achievement of Castration and Maintenance of Castration at Day 29. Started Jul 2006; status: completed.
02
Drugs
triptorelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00751790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00751790.